✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Sumitomo Pharma Co Ltd

Common Name
Sumitomo Pharma
Country
Japan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3,832
Ticker
4506
Exchange
TOKYO STOCK EXCHANGE
Description
Sumitomo Pharma Co., Ltd. is a prominent player in the global biopharmaceutical industry, primarily focused on the development, manufacturing, and marketing of pharmaceuticals. The company engages in ...

Sumitomo Pharma's Climate Target Data Preview

As of 2023, Sumitomo Pharma has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Sumitomo Pharma's climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Absolute-based Target
Scope 3 - Purchased Goods and Services (Cat. 1)
Metric Tonnes of CO2 equivalent (mtCO2e)
Copy/Paste is a PRO feature.
a
2030
Absolute-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e)
0000000
2030
Limited Data Preview
You are viewing a limited preview of Sumitomo Pharma’s Climate Target dataset. The full dataset, available for download, includes detailed baseline information for both absolute and intensity targets, along with reported progress and achievement details as of 2023.
Unrestricted Access to Data and Sources
pro
Remove manual data sourcing from your workflow. Upgrade to Tracenable Pro for unrestricted access to datasets and disclosures across 8,500+ companies with over 10 years of historical coverage.
Download complete datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace values back to original sources
Formats Included
Excel
CSV
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Sumitomo Pharma’s Climate Targets Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sumitomo Pharma’s data sources below and access millions more through our Disclosure Search.

a. Sumitomo Pharma's Integrated Report 2023

Insights into Sumitomo Pharma's Greenhouse Gas Emissions Pathways

As of 2023, Sumitomo Pharma has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.a

Does Sumitomo Pharma have a target to reduce the emissions from its operations?

As of 2023, Sumitomo Pharma has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a

Sumitomo Pharma's most ambitious operational target is to reduce these emissions by 42% by 2030, compared to a baseline of 72,519 Metric Tonnes of CO2 equivalent (mtCO2e) in 2020.a

As of 2022, Sumitomo Pharma is ahead of schedule on its operational emissions reduction target, having achieved 59.52% of the planned reduction.a

Sumitomo Pharma's Operational (Scope 1+2) Emissions Pathway

202020222030020 k40 k60 k80 kBaselineCurrent (-25%)Target 2030 (-42%)
Want Full Access to Sumitomo Pharma's Climate Targets Dataset?
Sign Up